Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hikma Pharmaceuticals plc

Latest From Hikma Pharmaceuticals plc

Vyvanse Generics Roll Out In US As Suppliers Work To Meet Demand

Hot on the heels of multiple US FDA approvals for rivals to the blockbuster ADHD brand Vyvanse, generics suppliers have confirmed launches – and with drugs in this category currently facing shortages, developers are eyeing significant demand.

Generic Drugs Launches

Aurobindo’s Pediatric AIDS Combo Generic Approved; Eugia Restructuring Back On Cards

A US FDA tentative approval for Aurobindo’s dolutegravir combination generic for children should increase access under the PEPFAR program and aid sales. On a Q1 earnings call, renewed efforts to restructure Eugia, biosimilar launch plans and fallouts of oral drug shortages and damage to Pfizer’s US injectables warehouse were discussed.

Approvals Strategy

Hikma Eyes Innovation With MENA Deals

Hikma has struck two deals in the MENA region, outlining agreements with Rakuten Medical and SK Biopharmaceuticals that focus on innovative assets.

Deals Strategy

Sun Pharma Seeks Recall Of Unapproved Phenobarbital Following Approval Of Its Product

Since FDA has approved Sezaby there is no reason for continued use of unapproved phenobarbital sodium products, firm tells FDA. Sun cites risks to neonates from three excipients in these products. The seizure drug has been marketed since 1940.

FDA Drug Safety
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Custopharm, Inc.
    • EIMC United Pharmaceuticals
    • Roxane Laboratories, Inc.
    • West-Ward Pharmaceuticals Corp.